Related Experiment Video

Updated: Dec 22, 2025

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
08:09

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats

Published on: December 13, 2019

22.5K

Asymptomatic Left Ventricle Systolic Dysfunction

Jaskanwal D Sara1, Takumi Toya1,2, Riad Taher1

  • 1Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science Rochester, MN, US.

European Cardiology
|May 7, 2020
PubMed

Insights

Early detection of asymptomatic left ventricular systolic dysfunction (ALVSD) is crucial for better heart failure outcomes. Managing stage B heart failure before symptoms appear can improve patient prognosis and reduce healthcare costs.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Clinical Medicine

Background:

  • Heart failure is a major cause of morbidity and mortality, with significant societal costs.
  • Current guidelines focus on symptomatic heart failure, yet early intervention is needed.
  • Asymptomatic left ventricular systolic dysfunction (ALVSD) represents an opportunity for early management.

Purpose of the Study:

  • To clarify the definition and natural history of ALVSD (Stage B heart failure).
  • To outline clinical tools for identifying patients with ALVSD.
  • To highlight future research directions for ALVSD.

Main Methods:

  • Review of current literature and guidelines on heart failure management.
  • Analysis of diagnostic criteria for ALVSD.
  • Discussion of therapeutic strategies for early intervention.

Main Results:

  • ALVSD is characterized by depressed left ventricular systolic function without clinical symptoms.
  • Early treatment initiation in ALVSD is associated with improved patient outcomes.
  • Several clinical tools can aid in the identification of ALVSD.

Conclusions:

  • Managing ALVSD is essential for improving long-term heart failure outcomes.
  • Further research is needed to fully understand and manage this condition.
  • Early identification and intervention in ALVSD can mitigate disease progression.

Keywords:
Asymptomaticheart failureleft ventricular dysfunctionsystolic impairment

More Related Videos

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

3.2K
Evaluation of Left Ventricular Structure and Function using 3D Echocardiography06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

4.4K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
278
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
335
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
284
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
153
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
274
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
585